Domov › Psoriatični artritis › North Carolina
Klinične študije za Psoriatični artritis v North Carolina
11 študij za Psoriatični artritis išče udeležence na lokacijah v North Carolina.
Mesta v North Carolina
Uradno besedilo študije (angleško)
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06807424A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Joint and Muscle Research Institute, Charlotte
- Onsite Clinical Solutions, Salisbury
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07321873A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 106, Chapel Hill
- Up0122 102, Durham
Vključevanje udeležencevFaza 1
Starost 18 in več · Ženske · Posodobljeno 18. sep. 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Accellacare of Hickory, Hickory
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Joint and Muscle Research Institute ( Site 5108), Charlotte
Vključevanje udeležencevFaza 2
Starost 18–80 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Charlotte
- Clinical Site, Leland
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- DJL Clinical Research | Charlotte, NC, Charlotte
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06671496A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- University of North Carolina - Children's Hospital /ID# 259286, Chapel Hill
Vključevanje udeležencevFaza 3
Starost 5–17 · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06100744A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
- University of North Carolina at Chapel Hill, Chapel Hill
Vključevanje udeležencevFaza 4
Starost 18 in več · Ženske · Posodobljeno 28. avg. 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Children's Hospital / Carolinas Medical Center, Charlotte
- Duke Children's Hospital & Health Center, Durham
- in še 1
Vključevanje udeležencevOpazovalna študija
Do 21 let · Vsi spoli · Posodobljeno 27. avg. 2026 · NCT02418442Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Evidera, a PPD Business Unit /ID# 238688, Morrisville
Vključevanje udeležencevOpazovalna študija
Vse starosti · Ženske · Posodobljeno 17. jul. 2025 · NCT04846959Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.